Degenerative Neurological and Neuromuscular Disease

Scope & Guideline

Unraveling the complexities of degenerative diseases.

Introduction

Welcome to the Degenerative Neurological and Neuromuscular Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Degenerative Neurological and Neuromuscular Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationDEGENER NEUROL NEURO / Degener. Neurol. Neuromuscul. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal "Degenerative Neurological and Neuromuscular Disease" focuses on advancing the understanding and treatment of various neurodegenerative and neuromuscular conditions. It aims to bridge basic research with clinical applications, enhancing the quality of life for affected individuals through innovative therapies and diagnostic techniques.
  1. Neurodegenerative Diseases:
    The journal extensively covers research on neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease, exploring their pathophysiology, biomarkers, and therapeutic interventions.
  2. Neuromuscular Disorders:
    Research on neuromuscular diseases, including but not limited to Duchenne muscular dystrophy and myasthenia gravis, is a core focus, addressing both clinical manifestations and potential treatment strategies.
  3. Innovative Therapies and Interventions:
    The publication emphasizes novel therapeutic approaches, including pharmacological treatments, lifestyle interventions, and complementary therapies like acupuncture, highlighting their efficacy and mechanisms.
  4. Biomarkers and Diagnostic Tools:
    There is a strong emphasis on identifying and validating biomarkers for early diagnosis and monitoring disease progression, with particular attention to blood and serum-based biomarkers.
  5. Quality of Life and Patient-Centered Research:
    The journal also prioritizes studies that assess the impact of various diseases and treatments on patients' quality of life, advocating for holistic and patient-centered care.
The journal has witnessed a shift in focus towards several emerging themes that reflect current trends in research and clinical practice in the fields of neurodegenerative and neuromuscular diseases. These topics are gaining traction and may shape future investigations.
  1. Blood Biomarkers for Alzheimer’s Disease:
    There is a notable increase in studies exploring blood biomarkers, which are crucial for early diagnosis and monitoring of Alzheimer's disease, reflecting advancements in detection technologies.
  2. Multimodal Interventions for Quality of Life:
    Research focusing on comprehensive lifestyle interventions, such as diet and exercise programs, designed to improve the quality of life for patients with multiple sclerosis and other neurodegenerative conditions is on the rise.
  3. Neuroinflammation and Neuroprotective Strategies:
    Emerging studies are increasingly investigating the role of neuroinflammation in neurodegenerative diseases, with a focus on neuroprotective strategies that target inflammatory pathways.
  4. Case Reports and Newborn Screening:
    There is a growing trend towards detailed case reports and advocacy for newborn screening in conditions like cerebral adrenoleukodystrophy, highlighting a shift towards early detection and intervention.
  5. Sexual Health in Neurological Disorders:
    Research addressing sexual health and motivation in individuals with neurological disorders is gaining attention, emphasizing the importance of holistic care that includes sexual well-being.

Declining or Waning

While the journal maintains a broad focus on various aspects of neurodegenerative and neuromuscular diseases, certain themes appear to be declining in prominence. This shift may reflect changing research priorities or a maturation of knowledge in these areas.
  1. Traditional Herbal Medicine:
    The interest in traditional herbal remedies for treating neurodegenerative diseases, while still present, has been overshadowed by more contemporary pharmacological approaches and clinical trials.
  2. Vitamin D and Neurological Health:
    Research specifically linking vitamin D deficiency to neurological conditions, such as Parkinson's disease, has seen a decrease, possibly due to inconclusive results and a shift towards more complex biochemical interactions.
  3. Sex Differences in Neurological Outcomes:
    While sex differences were previously a significant focus, recent publications indicate a waning interest in this area, as research moves towards more integrated approaches that do not segregate findings by sex.

Similar Journals

MUSCLE & NERVE

Elevating Understanding in Neurology and Physiology
Publisher: WILEYISSN: 0148-639XFrequency: 12 issues/year

MUSCLE & NERVE is a prestigious journal dedicated to the exploration and advancement of knowledge in the fields of neurology, cellular and molecular neuroscience, and physiology. Published by Wiley, this journal has been a crucial resource for researchers and practitioners since its inception in 1978, with an impressive convergence of studies anticipated through 2024. With an Impact Factor reflecting its relevance and influence—ranking in the Q2 and Q3 quartiles across multiple categories, including clinical neurology and medical physiology—MUSCLE & NERVE offers a rigorous peer-reviewed platform for groundbreaking research. It holds a respected position in Scopus rankings, illustrating its commitment to excellence and innovation in medicine and neuroscience. As a non-open access journal, it provides valuable resources for professionals seeking to further their understanding of neuromuscular physiology and related disciplines. The journal aims to foster dialogue and disseminate knowledge that advances the field, making it an indispensable tool for academics and clinicians alike.

Turkish Journal of Neurology

Illuminating the path to neurological advancements.
Publisher: GALENOS PUBL HOUSEISSN: 1301-062XFrequency: 4 issues/year

Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.

Neurodegenerative Diseases

Advancing understanding of neurodegenerative disorders.
Publisher: KARGERISSN: 1660-2854Frequency: 4 issues/year

Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.

Journal of Central Nervous System Disease

Exploring the frontiers of neuroscience.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5735Frequency: 1 issue/year

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Nature Reviews Neurology

Empowering Minds through Cutting-edge Neurological Reviews.
Publisher: NATURE PORTFOLIOISSN: 1759-4758Frequency: 12 issues/year

Nature Reviews Neurology, published by NATURE PORTFOLIO, stands as a leading scholarly journal dedicated to the field of neurology and neuroscience. With an impressive impact factor and a prestigious Q1 categorization in both Cellular and Molecular Neuroscience and Clinical Neurology, this journal provides cutting-edge reviews and insights into the latest research developments, trends, and clinical practices. Based in the United Kingdom and accessible to a global audience, Nature Reviews Neurology aims to foster knowledge dissemination and interdisciplinary collaboration among researchers, healthcare professionals, and educators. With an influential Scopus ranking, it remains a pivotal resource for those seeking to deepen their understanding of neurological disorders and therapies while remaining at the forefront of academic discourse and innovation in the field.

INTERNATIONAL JOURNAL OF NEUROSCIENCE

Fostering Collaboration in the World of Neuroscience
Publisher: TAYLOR & FRANCIS LTDISSN: 0020-7454Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF NEUROSCIENCE, published by TAYLOR & FRANCIS LTD, stands as a vital resource in the field of neuroscience since its inception. With a proud history of publication from 1970 to 2024, this journal is committed to advancing knowledge in various domains of neuroscience, from fundamental research to clinical applications. It is indexed with an ISSN of 0020-7454 and an E-ISSN of 1563-5279, reflecting its wide reach and recognition. The journal maintains a respectable position in the academic landscape, categorized as Q2 in Medicine (miscellaneous) and Q3 in Neuroscience (miscellaneous) as of 2023, signifying its relevance among researchers and professionals. Although it currently does not offer open access, the journal remains a significant platform for disseminating groundbreaking research, thereby fostering collaboration and innovation within the neuroscience community. Located in the United Kingdom, the journal aims to bridge gaps in neuroscience knowledge, making it an essential reading for students, professionals, and researchers dedicated to unraveling the complexities of the nervous system.

KLINISCHE NEUROPHYSIOLOGIE

Connecting researchers to advance neurological science.
Publisher: GEORG THIEME VERLAG KGISSN: 1434-0275Frequency: 4 issues/year

KLINISCHE NEUROPHYSIOLOGIE is a pivotal journal dedicated to advancing the field of clinical neurophysiology, published by GEORG THIEME VERLAG KG in Germany. With an ISSN of 1434-0275 and an E-ISSN of 1439-4081, this journal aims to disseminate high-quality research findings that enhance our understanding of neurological disorders and their physiological underpinnings. Although currently positioned in the fourth quartile in both Neurology (clinical) and Physiology (medical) categories, the journal offers a unique platform for novel insights and empirical studies, filling a crucial niche within the medical community. Researchers, healthcare professionals, and students can benefit from its Open Access option, which promotes wider accessibility and engagement with cutting-edge scientific discourse. As the journal converges through the years from 1998 to 2024, it remains committed to fostering scholarly collaboration and innovation in neurophysiological research, crucial for improving clinical outcomes.

NEUROLOGICAL RESEARCH

Pioneering Insights in Neurology and Clinical Advances
Publisher: TAYLOR & FRANCIS LTDISSN: 0161-6412Frequency: 12 issues/year

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

PRACTICAL NEUROLOGY

Bridging Research and Practice in Neurology
Publisher: BMJ PUBLISHING GROUPISSN: 1474-7758Frequency: 6 issues/year

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

CURRENT OPINION IN NEUROLOGY

Uncovering Breakthroughs in Neurological Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.